Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 44 |
| List of Tables | 39 | 6 |
| List of Figures | 45 | 1 |
| Introduction | 46 | 1 |
| Global Markets Direct Report Coverage | 46 | 1 |
| Parkinson's Disease Overview | 47 | 1 |
| Therapeutics Development | 48 | 2 |
| Pipeline Products for Parkinson's Disease Overview | 48 | 1 |
| Pipeline Products for Parkinson's Disease Comparative Analysis | 49 | 1 |
| Parkinson's Disease Therapeutics under Development by Companies | 50 | 16 |
| Parkinson's Disease Therapeutics under Investigation by Universities/Institutes | 66 | 3 |
| Parkinson's Disease Pipeline Products Glance | 69 | 4 |
| Late Stage Products | 69 | 1 |
| Clinical Stage Products | 70 | 1 |
| Early Stage Products | 71 | 1 |
| Unknown Stage Products | 72 | 1 |
| Parkinson's Disease Products under Development by Companies | 73 | 18 |
| Parkinson's Disease Products under Investigation by Universities/Institutes | 91 | 4 |
| Parkinson's Disease Companies Involved in Therapeutics Development | 95 | 179 |
| AC Immune SA | 95 | 1 |
| Acelot, Inc. | 96 | 1 |
| Acorda Therapeutics, Inc. | 97 | 1 |
| Addex Therapeutics Ltd | 98 | 1 |
| Advinus Therapeutics Ltd | 99 | 1 |
| Aeolus Pharmaceuticals, Inc. | 100 | 1 |
| AFFiRiS AG | 101 | 1 |
| Alexza Pharmaceuticals, Inc. | 102 | 1 |
| Amabiotics SAS | 103 | 1 |
| Amarantus Bioscience Holdings, Inc. | 104 | 1 |
| American Gene Technologies International Inc. | 105 | 1 |
| Anavex Life Sciences Corp. | 106 | 1 |
| Angita B.V. | 107 | 1 |
| Antoxis Limited | 108 | 1 |
| APeT Holding BV | 109 | 1 |
| ApoPharma Inc. | 110 | 1 |
| Aposense Ltd. | 111 | 1 |
| Araclon Biotech, S.L. | 112 | 1 |
| ArmaGen Inc. | 113 | 1 |
| Arrien Pharmaceuticals, LLC | 114 | 1 |
| AstraZeneca Plc | 115 | 1 |
| Berg LLC | 116 | 1 |
| Bial - Portela &Ca, S.A. | 117 | 1 |
| Bio-Modeling Systems SAS | 118 | 1 |
| BioArctic Neuroscience AB | 119 | 1 |
| Biogen, Inc. | 120 | 1 |
| Bionature E.A. Ltd. | 121 | 1 |
| Biopharm GmbH | 122 | 1 |
| Biotie Therapies Corp. | 123 | 1 |
| BrainStorm Cell Therapeutics Inc. | 124 | 1 |
| CalAsia Pharmaceuticals, Inc. | 125 | 1 |
| Calico LLC | 126 | 1 |
| Cardax Pharmaceuticals, Inc. | 127 | 1 |
| Carna Biosciences, Inc. | 128 | 1 |
| Cell Cure Neurosciences, Ltd. | 129 | 1 |
| Cellceutix Corporation | 130 | 1 |
| CHA Bio &Diostech Co., Ltd. | 131 | 1 |
| Chipscreen Biosciences Ltd | 132 | 1 |
| Clera Inc. | 133 | 1 |
| Clevexel Pharma SAS | 134 | 1 |
| Contera Pharma ApS | 135 | 1 |
| ContraVir Pharmaceuticals, Inc. | 136 | 1 |
| Corium International, Inc. | 137 | 1 |
| Corvus Pharmaceuticals, Inc. | 138 | 1 |
| Curemark, LLC | 139 | 1 |
| Cynapsus Therapeutics Inc. | 140 | 1 |
| D-Pharm Ltd. | 141 | 1 |
| Depomed, Inc. | 142 | 1 |
| DermaXon, LLC | 143 | 1 |
| Diffusion Pharmaceuticals Inc. | 144 | 1 |
| Dizlin Medical Design AB | 145 | 1 |
| Domain Therapeutics SA | 146 | 1 |
| Edison Pharmaceuticals, Inc. | 147 | 1 |
| Eli Lilly and Company | 148 | 1 |
| Ensemble Therapeutics Corporation | 149 | 1 |
| Euroscreen S.A. | 150 | 1 |
| FPRT Bio Inc. | 151 | 1 |
| Gene Solutions LLC | 152 | 1 |
| Genecode AS | 153 | 1 |
| Genentech, Inc. | 154 | 1 |
| Genervon Biopharmaceuticals, LLC | 155 | 1 |
| GenKyoTex S.A. | 156 | 1 |
| Genosco | 157 | 1 |
| Genzyme Corporation | 158 | 1 |
| H. Lundbeck A/S | 159 | 1 |
| Harbor Therapeutics, Inc. | 160 | 1 |
| Heptares Therapeutics Limited | 161 | 1 |
| Herantis Pharma Plc | 162 | 1 |
| Hisamitsu Pharmaceutical Co., Inc. | 163 | 1 |
| Huons Co., Ltd. | 164 | 1 |
| Immune Design Corp. | 165 | 1 |
| Immungenetics AG | 166 | 1 |
| Impel NeuroPharma, Inc. | 167 | 1 |
| Intec Pharma ltd. | 168 | 1 |
| Integrative Research Laboratories Sweden AB | 169 | 1 |
| InterMed Discovery GmbH | 170 | 1 |
| International Stem Cell Corporation | 171 | 1 |
| Intra-Cellular Therapies, Inc. | 172 | 1 |
| Io Therapeutics, Inc. | 173 | 1 |
| Iproteos S.L. | 174 | 1 |
| Jeil Pharmaceutical Co., Ltd. | 175 | 1 |
| Kainos Medicine, Inc. | 176 | 1 |
| Khondrion BV | 177 | 1 |
| KineMed, Inc. | 178 | 1 |
| Kyowa Hakko Kirin Co., Ltd. | 179 | 1 |
| Lead Discovery Center GmbH | 180 | 1 |
| Ligand Pharmaceuticals, Inc. | 181 | 1 |
| Living Cell Technologies Limited | 182 | 1 |
| Longevity Biotech, Inc | 183 | 1 |
| Luye Pharma Group Ltd. | 184 | 1 |
| M et P Pharma AG | 185 | 1 |
| M's Science Corporation | 186 | 1 |
| M3 Biotechnology, Inc. | 187 | 1 |
| MedGenesis Therapeutix Inc. | 188 | 1 |
| Merck &Co., Inc. | 189 | 1 |
| Merz Pharma GmbH &Co. KgaA | 190 | 1 |
| Metabolic Solutions Development Company, LLC | 191 | 1 |
| Minerva Neurosciences, Inc. | 192 | 1 |
| Mission Therapeutics Limited | 193 | 1 |
| Mitochon Pharmaceuticals, Inc. | 194 | 1 |
| MitoDys Therapeutics Limited | 195 | 1 |
| Motac Neuroscience Limited | 196 | 1 |
| Netherlands Translational Research Center B.V. | 197 | 1 |
| Neuralstem, Inc. | 198 | 1 |
| Neuraltus Pharmaceuticals, Inc. | 199 | 1 |
| Neuren Pharmaceuticals Limited | 200 | 1 |
| NeuroDerm Ltd. | 201 | 1 |
| Neurodyn Inc. | 202 | 1 |
| NeuroNascent, Inc. | 203 | 1 |
| Neuronax SAS | 204 | 1 |
| NeurOp, Inc | 205 | 1 |
| NeuroPhage Pharmaceuticals, Inc. | 206 | 1 |
| Neuropore Therapies, Inc. | 207 | 1 |
| New World Laboratories, Inc. | 208 | 1 |
| Newron Pharmaceuticals S.p.A. | 209 | 1 |
| nLife Therapeutics, S.L. | 210 | 1 |
| NLS Pharma Group | 211 | 1 |
| Novartis AG | 212 | 1 |
| NsGene A/S | 213 | 1 |
| Omeros Corporation | 214 | 1 |
| Oncodesign SA | 215 | 1 |
| Ono Pharmaceutical Co., Ltd. | 216 | 1 |
| OPKO Health, Inc. | 217 | 1 |
| Orion Oyj | 218 | 1 |
| Oryzon Genomics S.A. | 219 | 1 |
| Osmotica Pharmaceutical Corp. | 220 | 1 |
| Oxford BioMedica Plc | 221 | 1 |
| Peptron, Inc. | 222 | 1 |
| Pfizer Inc. | 223 | 1 |
| Pharma Two B Ltd | 224 | 1 |
| PharmatrophiX, Inc. | 225 | 1 |
| Pharmaxis Limited | 226 | 1 |
| Pharmicell Co., Ltd. | 227 | 1 |
| Pharnext SAS | 228 | 1 |
| Prana Biotechnology Limited | 229 | 1 |
| Prexton Therapeutics SA | 230 | 1 |
| Primary Peptides, Inc. | 231 | 1 |
| Promentis Pharmaceuticals, Inc. | 232 | 1 |
| Promius Pharma, LLC | 233 | 1 |
| Proteostasis Therapeutics, Inc. | 234 | 1 |
| Prothena Corporation Plc | 235 | 1 |
| QR Pharma, Inc. | 236 | 1 |
| Raptor Pharmaceutical Corp. | 237 | 1 |
| Reliance Life Sciences Pvt. Ltd. | 238 | 1 |
| reMYND NV | 239 | 1 |
| Retrotope, Inc | 240 | 1 |
| RhinoCyte, Inc. | 241 | 1 |
| Saje Pharma, LLC | 242 | 1 |
| SanBio, Inc. | 243 | 1 |
| Saneron CCEL Therapeutics, Inc. | 244 | 1 |
| Saniona AB | 245 | 1 |
| Sellas Inc. | 246 | 1 |
| Serina Therapeutics, Inc. | 247 | 1 |
| Shire Plc | 248 | 1 |
| Sigma-Tau S.p.A. | 249 | 1 |
| SignPath Pharma Inc | 250 | 1 |
| Signum Biosciences, Inc. | 251 | 1 |
| SK Biopharmaceuticals Co., Ltd. | 252 | 1 |
| STATegics, Inc. | 253 | 1 |
| Stelic Institute &Co., Inc. | 254 | 1 |
| Synovo GmbH | 255 | 1 |
| Synthonics, Inc. | 256 | 1 |
| Takara Bio Inc. | 257 | 1 |
| Takeda Pharmaceutical Company Limited | 258 | 1 |
| TauRx Therapeutics Ltd. | 259 | 1 |
| TechnoPhage SA | 260 | 1 |
| Teikoku Pharma USA, Inc. | 261 | 1 |
| Teva Pharmaceutical Industries Ltd. | 262 | 1 |
| Titan Pharmaceuticals, Inc. | 263 | 1 |
| Trevena, Inc. | 264 | 1 |
| TyrNovo Ltd. | 265 | 1 |
| UCB S.A. | 266 | 1 |
| UniQure N.V. | 267 | 1 |
| Vanton Research Laboratory, LLC | 268 | 1 |
| Varinel, Inc. | 269 | 1 |
| VistaGen Therapeutics , Inc. | 270 | 1 |
| VivaCell Biotechnology Espana S.L. | 271 | 1 |
| Voyager Therapeutics, Inc. | 272 | 1 |
| Wellstat Therapeutics Corporation | 273 | 1 |
| Parkinson's Disease Therapeutics Assessment | 274 | 34 |
| Assessment by Monotherapy Products | 274 | 1 |
| Assessment by Combination Products | 275 | 1 |
| Assessment by Target | 276 | 18 |
| Assessment by Mechanism of Action | 294 | 10 |
| Assessment by Route of Administration | 304 | 2 |
| Assessment by Molecule Type | 306 | 2 |
| Drug Profiles | 308 | 526 |
| (acamprosate calcium + baclofen) Drug Profile | 308 | 2 |
| (carbidopa + levodopa prodrug) Drug Profile | 310 | 1 |
| (carbidopa + levodopa) Drug Profile | 311 | 3 |
| (carbidopa + levodopa) Drug Profile | 314 | 1 |
| (carbidopa + levodopa) Drug Profile | 315 | 1 |
| (carbidopa + levodopa) Drug Profile | 316 | 1 |
| (carbidopa + levodopa) ER Drug Profile | 317 | 2 |
| (carbidopa + levodopa) ER Drug Profile | 319 | 1 |
| (carbidopa + levodopa) SR Drug Profile | 320 | 1 |
| (pramipexole dihydrochloride + rasagiline mesylate) Drug Profile | 321 | 2 |
| AAD-2004 Drug Profile | 323 | 1 |
| ADA-409 Drug Profile | 324 | 2 |
| ADX-88178 Drug Profile | 326 | 2 |
| AEOL-11114 Drug Profile | 328 | 1 |
| AEOL-11203 Drug Profile | 329 | 1 |
| AEOL-11207 Drug Profile | 330 | 2 |
| AG-0029 Drug Profile | 332 | 1 |
| AGIL-AADC Drug Profile | 333 | 1 |
| AGPD Drug Profile | 334 | 1 |
| AGT-110 Drug Profile | 335 | 1 |
| AGT-115 Drug Profile | 336 | 1 |
| AGT-190 Drug Profile | 337 | 1 |
| AK-7 Drug Profile | 338 | 1 |
| alloswitch-1 Drug Profile | 339 | 1 |
| AMA-101 Drug Profile | 340 | 1 |
| AMRS-001 Drug Profile | 341 | 9 |
| AMT-090 Drug Profile | 350 | 1 |
| ANAVEX-141 Drug Profile | 351 | 1 |
| ANAVEX-273 Drug Profile | 352 | 8 |
| ANAVEX-371 Drug Profile | 360 | 2 |
| Anle-138b Drug Profile | 362 | 1 |
| Antibodies to Inhibit Amyloid Protein for CNS and Metabolic Disorders Drug Profile | 363 | 1 |
| Antibody for Neurodegenerative Diseases and Diabetes Drug Profile | 364 | 1 |
| Antisense Oligonucleotide to Inhibit GAD for Parkinson's Disease Drug Profile | 365 | 1 |
| aplindore fumarate Drug Profile | 366 | 1 |
| apomorphine hydrochloride Drug Profile | 367 | 8 |
| apomorphine hydrochloride Drug Profile | 375 | 1 |
| ATT-LD Drug Profile | 376 | 1 |
| AV-101 Drug Profile | 377 | 3 |
| AZ-009 Drug Profile | 380 | 1 |
| AZD-1480 Drug Profile | 381 | 2 |
| BAN-0805 Drug Profile | 383 | 1 |
| BIIB-054 Drug Profile | 384 | 1 |
| BNC-375 Drug Profile | 385 | 1 |